ENDO PHARMA LLC 4
Accession 0001209191-05-052613
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 7:58 PM ET
Size
40.9 KB
Accession
0001209191-05-052613
Insider Transaction Report
- Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$2.42/sh−2,456$5,944→ 22,418,138 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$3.00/sh−1,141$3,423→ 22,372,466 total - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$2.42/sh−16,165$39,119→ 355,116 totalExercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (16,165 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$2.42/sh−16,165$39,119→ 22,401,973 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$3.00/sh−589$1,767→ 22,373,607 total - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$3.00/sh−750$2,250→ 556,758 totalExercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (750 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$2.42/sh−5,198$12,579→ 22,420,594 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$2.42/sh−1,441$3,487→ 22,374,946 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$2.42/sh−18,445$44,637→ 22,383,528 total - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$3.42/sh−11,415$39,039→ 101,419 totalExercise: $3.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (11,415 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$2.42/sh−5,198$12,579→ 1,372,410 totalExercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (5,198 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$2.42/sh−7,141$17,281→ 412,791 totalExercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (7,141 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$2.42/sh−1,441$3,487→ 142,321 totalExercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (1,441 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$3.00/sh−589$1,767→ 122,444 totalExercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (589 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$2.42/sh−2,456$5,944→ 1,550,835 totalExercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (2,456 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$3.42/sh−11,415$39,039→ 22,361,051 total - Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$3.00/sh−750$2,250→ 22,374,196 total - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$2.42/sh−18,445$44,637→ 218,070 totalExercise: $2.42From: 2005-10-13Exp: 2007-08-26→ Common Stock (18,445 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2005-10-13$2.42/sh−7,141$17,281→ 22,376,387 total - Exercise of In-Money
Call Option (obligation to sell)
2005-10-13$3.00/sh−1,141$3,423→ 340,473 totalExercise: $3.00From: 2005-10-13Exp: 2007-08-26→ Common Stock (1,141 underlying)
Documents
Issuer
ENDO PHARMACEUTICALS HOLDINGS INC
CIK 0001100962
Related Parties
1- filerCIK 0001120075
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 7:58 PM ET
- Size
- 40.9 KB